What is the best medication for sacroiliac (SI) joint pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Medication for Sacroiliac (SI) Joint Pain

NSAIDs are the first-line medication for sacroiliac joint pain, used continuously for 2-4 weeks to evaluate response, with options including naproxen, ibuprofen, diclofenac, or COX-2 inhibitors. 1

Stepwise Medication Approach

First-Line Therapy

  • NSAIDs:
    • Use continuously for 2-4 weeks to properly evaluate response 1
    • Options include naproxen, ibuprofen, diclofenac, or COX-2 inhibitors
    • For patients with increased gastrointestinal risk: Use either selective COX-2 inhibitors or non-selective NSAIDs with gastroprotective agents 1
    • NSAIDs should be used as adjunct therapy, not as monotherapy for chronic, persistent synovitis 2

Second-Line Therapy (for inadequate NSAID response)

  • Corticosteroid Injections:
    • Conditionally recommended for isolated active sacroiliitis 1
    • Should be image-guided when available
    • Can provide pain relief for over 3 months in some patients 3
    • Local injections directed to the site of musculoskeletal inflammation 2

Third-Line Therapy (for refractory cases)

  • Biologics:
    • TNF inhibitors (first-line biologics): etanercept, adalimumab, golimumab 1
    • IL-17 inhibitors (for TNF inhibitor failures): secukinumab, ixekizumab 1
    • Anti-TNF therapy should be given to patients with persistently high disease activity despite conventional treatments 2

Fourth-Line Therapy

  • JAK inhibitors: Strongly recommended when biologics are contraindicated or unavailable 1

Other Medication Options

  • Analgesics:
    • Paracetamol (acetaminophen) and opioid-like drugs might be considered for residual pain after previously recommended treatments have failed 2
    • Should be used only after other options have been exhausted

Medications to Avoid or Use with Caution

  • Systemic glucocorticoids: Not supported by evidence for axial disease 2, 1
  • DMARDs (Disease-modifying antirheumatic drugs):
    • No evidence for efficacy in axial disease, including methotrexate 2
    • Sulfasalazine may be considered only if peripheral arthritis is present 2, 1

Interventional Procedures for Medication-Refractory Cases

  • Radiofrequency ablation (RFA):

    • Consider for patients who fail medication management 3
    • Cooled RFA may provide longer-lasting relief 1
    • Extensive lesioning strategies have the strongest evidence 3
  • SI joint fusion:

    • Reserved for patients with:
      • Positive response to SI injection with >75% relief
      • Failure of all nonsurgical treatments
      • Continued or recurrent SIJ pain 1, 4

Important Clinical Considerations

  • Use standardized measures like ASDAS to monitor disease activity and treatment response 1
  • Assess treatment response after 2-4 weeks of NSAID therapy 1
  • If a significant change in disease course occurs, consider causes other than inflammation, such as spinal fracture 2
  • Diagnostic SI joint blocks with local anesthetic can confirm the SI joint as pain source 1

Pitfalls to Avoid

  • Don't rely solely on imaging findings, as MRI findings may not always correlate with the location of pain 1
  • Avoid long-term systemic glucocorticoid use due to adverse effects 1
  • Don't use DMARDs for isolated SI joint pain without peripheral symptoms 2, 1
  • Avoid using NSAIDs as monotherapy for chronic, persistent synovitis 2

By following this stepwise medication approach, most patients with SI joint pain can achieve significant pain relief and improved function.

References

Guideline

Sacroiliac Joint Inflammation Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

5. Sacroiliac joint pain.

Pain practice : the official journal of World Institute of Pain, 2024

Research

Management of Sacroiliac Joint Pain.

The Journal of the American Academy of Orthopaedic Surgeons, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.